Department of Surgery, Memorial Sloan-Kettering Cancer Center, 275 York Avenue, New York, NY 10021, USA.
J Gastrointest Surg. 2012 May;16(5):889-96; discussion 896. doi: 10.1007/s11605-012-1845-2. Epub 2012 Feb 24.
Positive peritoneal cytology confers the same prognosis as clinical stage IV disease in gastric cancer. Conventional cytology examination, however, has low sensitivity. We hypothesize that real-time polymerase chain reaction (RT-PCR) may have increased sensitivity and provide more accurate staging information.
From February 2007 to April 2009, peritoneal lavage samples were collected prospectively from 156 patients with biopsy-proven gastric cancer undergoing staging laparoscopy. These washings were analyzed by both Papanicolaou staining and RT-PCR for the tumor marker carcinoembryonic antigen (CEA).
Visible peritoneal disease was seen at laparoscopy in 38 patients (LAP+, 24%). Cytology was positive (CYT+) in 23 patients, while RT-PCR was positive (PCR+) in 30. The sensitivity of CYT for the detection of visible disease was 61% compared to 79% for PCR (P = 0.02). No visible peritoneal disease was seen at laparoscopy (LAP-) in 118 (76%) patients. Eight (7%) were CYT+, while 28 (24%) were PCR+. Predictors of PCR positivity included advanced-stage disease (T3-4 vs. T1-2 tumors) and poor pathologic features such as vascular or perineural invasion. Long-term follow-up demonstrated a worse survival of LAP-CYT-PCR+ (P = 0.0003) and LAP-CYT+PCR+ (P = 0.0004) compared to LAP-CYT-PCR- patients. There was no significant difference in survival between CYT-PCR+ and CYT+PCR+ patients. PCR positivity also predicted a higher likelihood of disease recurrence after resection. An R0 resection was performed in 85 LAP- patients (54%): only 1 (1%) was CYT+, while 13 (15%) were PCR+. Of this group, PCR+ demonstrated a worse survival than PCR- patients (P = 0.02). Further analysis showed that, in R0 resection, stage III/IV, CYT- subgroup, PCR+ was associated with a trend towards worse survival (P = 0.09) compared to PCR- patients.
RT-PCR for CEA increases the detection of subclinical peritoneal disease and is more sensitive than cytology. Predictors of positive PCR included advanced-stage disease, vascular invasion, and perineural invasion. PCR positivity was associated with increased disease recurrence and decreased survival. Further follow-up is required to determine if PCR positivity alone is an independent predictor of poor survival in gastric cancer.
阳性腹膜细胞学检查与胃癌临床 IV 期疾病具有相同的预后。然而,常规细胞学检查的灵敏度较低。我们假设实时聚合酶链反应(RT-PCR)可能具有更高的灵敏度,并提供更准确的分期信息。
从 2007 年 2 月至 2009 年 4 月,前瞻性收集了 156 例经活检证实的胃癌患者行腹腔镜分期检查时的腹腔灌洗样本。这些洗液通过巴氏染色和 RT-PCR 分析肿瘤标志物癌胚抗原(CEA)。
腹腔镜下可见腹膜疾病 38 例(LAP+,24%)。细胞学阳性(CYT+)23 例,PCR 阳性(PCR+)30 例。CYT 检测肉眼可见疾病的灵敏度为 61%,而 PCR 的灵敏度为 79%(P=0.02)。腹腔镜下未见腹膜疾病(LAP-)118 例(76%)。8 例(7%)为 CYT+,28 例(24%)为 PCR+。PCR 阳性的预测因素包括晚期疾病(T3-4 与 T1-2 肿瘤)和血管或神经周围侵犯等不良病理特征。长期随访显示,LAP-CYT-PCR+(P=0.0003)和 LAP-CYT+PCR+(P=0.0004)患者的生存率明显低于 LAP-CYT-PCR-患者。CYT-PCR+和 CYT+PCR+患者的生存率无显著差异。PCR 阳性也预示着切除后疾病复发的可能性更高。85 例 LAP-患者行 R0 切除术(54%):仅 1 例(1%)为 CYT+,13 例(15%)为 PCR+。在这一组中,PCR+患者的生存率明显低于 PCR-患者(P=0.02)。进一步分析显示,在 R0 切除、III/IV 期、CYT-亚组中,与 PCR-患者相比,PCR+患者的生存趋势较差(P=0.09)。
CEA 的 RT-PCR 提高了亚临床腹膜疾病的检出率,比细胞学检查更敏感。PCR 阳性的预测因素包括晚期疾病、血管侵犯和神经周围侵犯。PCR 阳性与疾病复发增加和生存率降低有关。需要进一步随访以确定 PCR 阳性是否是胃癌不良生存的独立预测因素。